GlaxoSmithKline and Idenix Pharmaceuticals sign worldwide license agreement for IDX899
|
10 February 2009 |
GSK to drive growth in emerging markets with acquisition of UCB products
|
27 January 2009 |
GlaxoSmithKline successfully completes tender offer for shares of Genelabs Technologies, Inc.
|
08 January 2009 |
GlaxoSmithKline to cease providing corporate political contributions
|
23 December 2008 |
GSK analysis shows Seretide/Advair is a well tolerated and effective medicine
|
08 December 2008 |
GSK and Neptunus form joint venture for the co-development of flu vaccines
|
24 November 2008 |
GlaxoSmithKline to acquire Genelabs Technologies to increase focus on novel small molecule therapies
|
01 November 2008 |
GSKâs Emerging Markets strategy advances with acquisition in Egypt
|
20 October 2008 |
GSK responds to NICE's second technology appraisal consultation document on the use of Tyverb
|
15 October 2008 |
GlaxoSmithKline and Valeant Pharmaceuticals announce worldwide collaboration agreement
|
29 August 2008 |